The efficacy and safety of anti-EGFR target agents in patients with potentially resectable metastatic colorectal cancer: a meta-analysis of randomized controlled trials
Adding anti-epidermal growth factor receptor (anti-EGFR) target agents to conversion therapy may improve the resection rates and survival of patients with potentially resectable metastatic colorectal cancer (m...
Source: World Journal of Surgical Oncology - Category: Cancer & Oncology Authors: Yang Wang, Xiangyuan Li, Tongmin Huang, Dongying Wang, Yujing He, Mengfei Wei, Yujie Chen, Matao Zheng, Yetan Shi and Jianjian Zhang Tags: Research Source Type: research